Explore Diverse Perspectives.

Browser Extension

Monday, June 2, 2025

US Edition

Subscribe Login

Israel-Hamas Conflict

Artificial Intelligence

Champions League

PharmaVOICE image

News from PharmaVOICE

Topics Most Covered by PharmaVOICE

Sources Covering Similar Topics

biopharmadive.com

San Diego Union Tribune

biopharmadive.com

Suggest a source

Looking for a source we don't already have? Suggest one here.

News Home Page Local News Blindspot Feed International Covid-19

International North America South America Europe Asia Australia Africa

Trending Internationally Artificial Intelligence Social Media Drones Taxes Internet

Trending in U.S.Israel-Hamas Conflict US Politics US Economy Donald Trump Baseball

Trending in U.K.Israel-Hamas Conflict Premier League UK Politics Soccer Social Media

Trending Topics

Artificial Intelligence Social Media Drones Taxes Israel-Hamas Conflict

CompanyAbout History Mission Blog Testimonials Group Subscriptions Subscribe Gift Free Trial Careers Affiliates

HelpHelp Center FAQ Contact Us For Educators/Libraries Media Bias Ratings Ownership and Factuality Ratings Referral Code News Sources Topics

ToolsApp Browser Extension Daily Newsletter Blindspot Report Newsletter Burst Your Bubble Newsletter Timelines

Gift Privacy Policy Manage Cookies Terms and Conditions

© 2025 Snapwise Inc

Search Blindspot Local

News from PharmaVOICE

Your destination for news from PharmaVOICE. See how PharmaVOICE’s media bias impacts the breaking news stories of today.

In total, 66 have been published by PharmaVOICE which Ground News has aggregated in the past 3 months.

The Ground News media bias check for PharmaVOICE is Center. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

PharmaVOICE’s aggregated factuality score is High. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Your destination for news from PharmaVOICE. See how PharmaVOICE’s media bias impacts the breaking news stories of today. In total, 66 have been published by PharmaVOICE which Ground News has aggregated in the past 3 months.

The Ground News media bias check for PharmaVOICE is Center. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides. PharmaVOICE’s aggregated factuality score is High. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about PharmaVOICE

Where is PharmaVOICE located?PharmaVOICE's Website

Media Bias Ratings

Average Bias Rating:

Center

Center

byMedia Bias/Fact Check

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Breaking News Topics Related to PharmaVOICE

Pharma

Health

Donald Trump

United States

Similar News Topics

biopharmadive.com

Bloomberg

STAT

The Independent

San Diego Union Tribune

Top PharmaVOICE News

Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million

23andMe · United States

Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million

63% Center coverage: 132 sources

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, the companies said on Monday.See the Story

Guinness maker Diageo braces for £113m US tariff impact

Keir Starmer · United Kingdom

Guinness maker Diageo braces for £113m US tariff impact

50% Center coverage: 14 sources

New Drug Could Lower Risk of Alzheimer's Disease, Study Finds

Alzheimer's Disease

New Drug Could Lower Risk of Alzheimer's Disease, Study Finds

100% Center coverage: 8 sources

Researchers in a new study found that the drug showed an ability to protect the brain in a certain way, which is a critical defense against Alzheimer’s disease.See the Story

Lilly Takes on Vertex in Non-Opioid Pain with SiteOne Buy

Lilly Takes on Vertex in Non-Opioid Pain with SiteOne Buy

100% Center coverage: 3 sources

Lilly buys SiteOne in a $1bn deal that would give it a rival to Vertex's approved painkiller Journavx, and a partnership on another programmeEli Lilly · United States See the Story

The MAHA agenda won’t include expanding GLP-1 coverage

The MAHA agenda won’t include expanding GLP-1 coverage

100% Center coverage: 1 sources

Despite axing a Biden-era proposal for government coverage of obesity drugs, health officials have signaled a potential path forward.United States · United States Read Article

AbbVie’s ADC win shows how pharma can break through in solid tumors

AbbVie’s ADC win shows how pharma can break through in solid tumors

100% Center coverage: 1 sources

An oncology pivot recently paid off for the large pharma, which scored a milestone nod for its lead ADC.United States · United States Read Article

Tying U.S. Drug Prices To Foreign Markets Risks Innovation And Lives

Tying U.S. Drug Prices To Foreign Markets Risks Innovation And Lives

100% Center coverage: 2 sources

Pegging drug prices here to those in other countries would yield minimal savings for the United States and devastate funding for biomedical research.Donald Trump · United States See the Story

Turning the page: Novo’s CEO transition reflects Big Pharma’s era of change

Turning the page: Novo’s CEO transition reflects Big Pharma’s era of change

100% Center coverage: 1 sources

Turnover of the top execs at pharma giants like J&J, AbbVie and Merck in the last few years illustrates the seismic industry shifts that often accompany leadership changes.Pharma Read Article

Lilly’s former small molecule head makes the leap to a rising biotech in obesity

Lilly’s former small molecule head makes the leap to a rising biotech in obesity

100% Center coverage: 1 sources

Utpal Singh joined the peptide-focused biotech Zealand Pharma last month after it notched a massive obesity deal with Roche.Obesity · Denmark Read Article

The placebo effect: How a new FDA rule could pile more strain onto vaccine developers

The placebo effect: How a new FDA rule could pile more strain onto vaccine developers

100% Center coverage: 1 sources

The proposed plan would require placebo testing for all new vaccines and could mean additional costs and time for R&D.Vaccines · United States Read Article

With the third round of Medicare price negotiations on the way, here’s how the policy is shifting

With the third round of Medicare price negotiations on the way, here’s how the policy is shifting

100% Center coverage: 1 sources

HHS issued guidance for the third cycle, teeing up another 15 drugs to be selected by early next year.Medicare · United States Read Article